Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 10 05 2023
accepted: 20 06 2023
medline: 21 7 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: epublish

Résumé

While estrogens are well known for their pivotal role in the female reproductive system, they also play a crucial function in regulating physiological processes associated with learning and memory in the brain. Moreover, they have neuroprotective effects in the pathogenesis of Alzheimer's disease (AD). Importantly, AD has a higher incidence in older and postmenopausal women than in men, and estrogen treatment might reduce the risk of AD in these women. In general, estrogens bind to and activate estrogen receptors (ERs)-mediated transcriptional machineries, and also stimulate signal transduction through membrane ERs (mERs). Estrogen-related receptors (ERRs), which share homologous sequences with ERs but lack estrogen-binding capabilities, are widely and highly expressed in the human brain and have also been implicated in AD pathogenesis. In this review, we primarily provide a summary of ER and ERR expression patterns in the human brain. In addition, we summarize recent studies on their role in learning and memory. We then review and discuss research that has elucidated the functions and importance of ERs and ERRs in AD pathogenesis, including their role in Aβ clearance and the reduction of phosphorylated tau levels. Elucidation of the mechanisms underlying ER- and ERR-mediated transcriptional machineries and their functions in healthy and diseased brains would provide new perspectives for the diagnosis and treatment of AD. Furthermore, exploring the potential role of estrogens and their receptors, ERs, in AD will facilitate a better understanding of the sex differences observed in AD, and lead to novel sex-specific therapeutic approaches.

Identifiants

pubmed: 37469978
doi: 10.3389/fendo.2023.1220150
pmc: PMC10352578
doi:

Substances chimiques

Receptors, Estrogen 0
Estrogens 0
Neuroprotective Agents 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220150

Informations de copyright

Copyright © 2023 Sato, Takayama and Inoue.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Cell Endocrinol. 2014 May 25;389(1-2):7-12
pubmed: 24508665
Neural Regen Res. 2019 Dec;14(12):2069-2070
pubmed: 31397335
Neurobiol Aging. 2007 Nov;28(11):1670-81
pubmed: 17010478
Brain Res. 1998 Mar 30;788(1-2):320-2
pubmed: 9555076
Endocrinology. 2004 Aug;145(8):3788-95
pubmed: 15131017
J Neuropathol Exp Neurol. 2012 May;71(5):362-81
pubmed: 22487856
Neurobiol Aging. 2001 May-Jun;22(3):417-26
pubmed: 11378248
Acta Neuropathol. 2003 Sep;106(3):213-20
pubmed: 12819990
Mol Cell Endocrinol. 2007 Feb;265-266:138-42
pubmed: 17222505
Mol Cell Endocrinol. 1998 Nov 25;146(1-2):59-68
pubmed: 10022763
Cell Rep. 2015 Apr 21;11(3):344-50
pubmed: 25865889
J Mol Biol. 2003 Apr 4;327(4):819-32
pubmed: 12654265
J Neurosci. 1992 Aug;12(8):3217-25
pubmed: 1353794
Front Biosci (Landmark Ed). 2011 Jan 01;16(4):1560-73
pubmed: 21196248
Endocrinology. 1999 Feb;140(2):660-6
pubmed: 9927291
Nat Rev Dis Primers. 2021 May 13;7(1):33
pubmed: 33986301
Steroids. 2011 Aug;76(9):840-4
pubmed: 21354436
J Biol Chem. 2015 Dec 25;290(52):30670-83
pubmed: 26542804
Exp Neurol. 2003 Oct;183(2):482-8
pubmed: 14552888
J Exp Neurosci. 2016 May 05;9(Suppl 2):93-121
pubmed: 27168725
J Physiol Pharmacol. 2013 Apr;64(2):129-42
pubmed: 23756388
Biochim Biophys Acta Bioenerg. 2018 Jun;1859(6):423-433
pubmed: 29550215
Front Endocrinol (Lausanne). 2021 May 19;12:682012
pubmed: 34093446
Int J Mol Sci. 2023 Jan 17;24(3):
pubmed: 36768177
Brain Res Mol Brain Res. 2000 May 5;77(2):277-80
pubmed: 10837923
J Endocrinol. 2009 Aug;202(2):223-36
pubmed: 19420011
Vitam Horm. 2018;107:155-175
pubmed: 29544629
Biology (Basel). 2023 Jan 09;12(1):
pubmed: 36671793
Horm Behav. 1998 Oct;34(2):149-62
pubmed: 9799625
Cell. 2006 Aug 25;126(4):789-99
pubmed: 16923397
Nat Rev Endocrinol. 2011 Aug 16;7(12):715-26
pubmed: 21844907
Horm Behav. 2015 Aug;74:125-38
pubmed: 26122294
Brain Res. 2000 Feb 21;856(1-2):142-51
pubmed: 10677621
Brain Res. 2001 Jul 27;908(2):113-9
pubmed: 11454321
Mol Endocrinol. 2006 Feb;20(2):302-10
pubmed: 16150865
J Natl Cancer Inst Monogr. 2000;(27):113-24
pubmed: 10963623
Neuroscientist. 2014 Oct;20(5):426-31
pubmed: 24122821
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
J Biol Chem. 2010 Jan 8;285(2):935-42
pubmed: 19897485
Nat Neurosci. 2001 Mar;4(3):233-4
pubmed: 11224536
Ann N Y Acad Sci. 2006 Nov;1089:324-42
pubmed: 17261779
Arch Neurol. 2009 Mar;66(3):352-61
pubmed: 19273754
Reproduction. 2020 Mar 01;159(3):R125-R137
pubmed: 32040278
Neuron. 2012 Jun 7;74(5):801-8
pubmed: 22681685
J Headache Pain. 2020 Nov 10;21(1):131
pubmed: 33167864
Physiol Rev. 2017 Jul 1;97(3):1045-1087
pubmed: 28539435
Neuroendocrinology. 2012;96(2):103-10
pubmed: 22538318
Cell Metab. 2015 Apr 7;21(4):628-36
pubmed: 25863252
Reprod Med Biol. 2016 Dec 05;16(1):4-20
pubmed: 29259445
Front Aging Neurosci. 2019 Sep 06;11:242
pubmed: 31551757
J Neurosci. 2003 Jun 1;23(11):4479-90
pubmed: 12805288
Maturitas. 2007 May 20;57(1):20-2
pubmed: 17350773
Sci Rep. 2016 Feb 03;6:20352
pubmed: 26837465
Endocr Rev. 2008 Oct;29(6):677-96
pubmed: 18664618
Ageing Res Rev. 2021 Dec;72:101464
pubmed: 34551326
Neurology. 1999 Dec 10;53(9):1992-7
pubmed: 10599770
Mol Brain. 2016 Mar 17;9:27
pubmed: 26983404
Neuropsychopharmacology. 2012 Sep;37(10):2299-309
pubmed: 22669167
Am J Pathol. 2021 Sep;191(9):1490-1498
pubmed: 34102108
J Biol Chem. 2009 Apr 3;284(14):9540-8
pubmed: 19189968
J Neurosci. 2010 Dec 1;30(48):16137-48
pubmed: 21123560
Mol Cancer. 2013 Feb 04;12:9
pubmed: 23379261
Brain Res. 2017 Mar 15;1659:71-80
pubmed: 28119057
Front Biosci (Schol Ed). 2017 Jan 1;9(1):111-126
pubmed: 27814578
Neurobiol Aging. 2003 Oct;24(6):817-28
pubmed: 12927764
Cell Metab. 2013 Nov 5;18(5):649-59
pubmed: 24120943
Biochem Biophys Res Commun. 2004 Feb 20;314(4):964-70
pubmed: 14751226
Mol Cell Neurosci. 2009 Nov;42(3):172-83
pubmed: 19595769
J Neuroendocrinol. 2012 Jan;24(1):236-48
pubmed: 22070562
Nat Rev Dis Primers. 2015 Oct 15;1:15056
pubmed: 27188934
Int J Mol Sci. 2023 Feb 17;24(4):
pubmed: 36835454
J Neurosci. 2009 Oct 14;29(41):12982-93
pubmed: 19828812
Gynecol Endocrinol. 2019 May;35(5):376-384
pubmed: 30793997
Nucl Recept Signal. 2016 Jun 21;14:e002
pubmed: 27507929
Biochem Biophys Res Commun. 2000 Apr 2;270(1):1-10
pubmed: 10733896
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S13-9
pubmed: 9330980
J Clin Endocrinol Metab. 2004 Apr;89(4):1912-25
pubmed: 15070964
Cell. 2019 Oct 3;179(2):312-339
pubmed: 31564456
Mech Dev. 1996 Feb;54(2):211-23
pubmed: 8652414
Front Aging. 2021 Aug 11;2:721579
pubmed: 35822056
Mol Cell Endocrinol. 2018 May 5;466:2-14
pubmed: 28851667
Neurotox Res. 2020 Dec;38(4):957-966
pubmed: 33025361
J Comp Neurol. 2007 Aug 20;503(6):790-802
pubmed: 17570500
Front Mol Biosci. 2022 Feb 23;9:839887
pubmed: 35281259
Front Aging Neurosci. 2023 May 03;15:1157818
pubmed: 37207075
Exp Neurol. 2003 Sep;183(1):159-72
pubmed: 12957499
J Steroid Biochem Mol Biol. 2018 Feb;176:57-64
pubmed: 28465157
Exp Neurol. 2018 Jul;305:89-96
pubmed: 29641978
Curr Issues Mol Biol. 2018;28:29-46
pubmed: 29388552
Acta Pharmacol Sin. 2015 Jan;36(1):24-31
pubmed: 25500870
Neurosci Lett. 2008 Jun 13;438(1):48-53
pubmed: 18472334
J Cell Biol. 2015 Sep 28;210(7):1225-37
pubmed: 26391661
Mol Brain. 2023 Jan 28;16(1):16
pubmed: 36709268
Science. 2020 Mar 6;367(6482):
pubmed: 32139519
Iran J Pharm Res. 2010 Spring;9(2):183-91
pubmed: 24363726
Front Endocrinol (Lausanne). 2022 Mar 01;13:827032
pubmed: 35299973
Biol Psychiatry. 2005 Nov 15;58(10):812-24
pubmed: 16112656
Brain Res. 2013 Jun 13;1514:75-82
pubmed: 23535448
Steroids. 2000 May;65(5):227-51
pubmed: 10751636
J Steroid Biochem Mol Biol. 2019 Jul;191:105380
pubmed: 31078693
J Clin Endocrinol Metab. 2000 Oct;85(10):3840-6
pubmed: 11061547
Int J Mol Sci. 2020 Sep 12;21(18):
pubmed: 32932692
Mol Cell. 2017 Sep 7;67(5):733-743.e4
pubmed: 28844863
Mol Neurodegener. 2019 Aug 2;14(1):32
pubmed: 31375134
Brain Res. 1995 Nov 27;700(1-2):245-53
pubmed: 8624717
J Alzheimers Dis. 2012;30(3):545-58
pubmed: 22451324
Annu Rev Pharmacol Toxicol. 2007;47:657-80
pubmed: 16918306
Front Physiol. 2011 Jun 03;2:23
pubmed: 21852974

Auteurs

Kaoru Sato (K)

Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Tokyo, Japan.
Integrated Research Initiative for Living Well with Dementia (IRIDE), TMIG, Tokyo, Japan.

Ken-Ichi Takayama (KI)

Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Tokyo, Japan.

Satoshi Inoue (S)

Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH